445 related articles for article (PubMed ID: 32942747)
1. HNSCC: Tumour Antigens and Their Targeting by Immunotherapy.
von Witzleben A; Wang C; Laban S; Savelyeva N; Ottensmeier CH
Cells; 2020 Sep; 9(9):. PubMed ID: 32942747
[TBL] [Abstract][Full Text] [Related]
2. Immunotherapy Advances in Locally Advanced and Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma and Its Relationship With Human Papillomavirus.
Wang H; Zhao Q; Zhang Y; Zhang Q; Zheng Z; Liu S; Liu Z; Meng L; Xin Y; Jiang X
Front Immunol; 2021; 12():652054. PubMed ID: 34305889
[TBL] [Abstract][Full Text] [Related]
3. HPV-positive status associated with inflamed immune microenvironment and improved response to anti-PD-1 therapy in head and neck squamous cell carcinoma.
Wang J; Sun H; Zeng Q; Guo XJ; Wang H; Liu HH; Dong ZY
Sci Rep; 2019 Sep; 9(1):13404. PubMed ID: 31527697
[TBL] [Abstract][Full Text] [Related]
4. PD-L1-specific helper T-cells exhibit effective antitumor responses: new strategy of cancer immunotherapy targeting PD-L1 in head and neck squamous cell carcinoma.
Hirata-Nozaki Y; Ohkuri T; Ohara K; Kumai T; Nagata M; Harabuchi S; Kosaka A; Nagato T; Ishibashi K; Oikawa K; Aoki N; Ohara M; Harabuchi Y; Uno Y; Takei H; Celis E; Kobayashi H
J Transl Med; 2019 Jun; 17(1):207. PubMed ID: 31221178
[TBL] [Abstract][Full Text] [Related]
5. Programmed Death-1/Programmed Death-Ligand 1-Axis Blockade in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma Stratified by Human Papillomavirus Status: A Systematic Review and Meta-Analysis.
Xu Y; Zhu G; Maroun CA; Wu IXY; Huang D; Seiwert TY; Liu Y; Mandal R; Zhang X
Front Immunol; 2021; 12():645170. PubMed ID: 33897693
[TBL] [Abstract][Full Text] [Related]
6. A digital score of tumour-associated stroma infiltrating lymphocytes predicts survival in head and neck squamous cell carcinoma.
Shaban M; Raza SEA; Hassan M; Jamshed A; Mushtaq S; Loya A; Batis N; Brooks J; Nankivell P; Sharma N; Robinson M; Mehanna H; Khurram SA; Rajpoot N
J Pathol; 2022 Feb; 256(2):174-185. PubMed ID: 34698394
[TBL] [Abstract][Full Text] [Related]
7. Tumor microenvironment modulation enhances immunologic benefit of chemoradiotherapy.
Hanoteau A; Newton JM; Krupar R; Huang C; Liu HC; Gaspero A; Gartrell RD; Saenger YM; Hart TD; Santegoets SJ; Laoui D; Spanos C; Parikh F; Jayaraman P; Zhang B; Van der Burg SH; Van Ginderachter JA; Melief CJM; Sikora AG
J Immunother Cancer; 2019 Jan; 7(1):10. PubMed ID: 30646957
[TBL] [Abstract][Full Text] [Related]
8. HPV and the Immune System in Head and Neck Cancers: Therapeutic Considerations.
Grinnell M; Krishnan M; Ganti AK
Oncology (Williston Park); 2020 Apr; 34(4):. PubMed ID: 32293695
[TBL] [Abstract][Full Text] [Related]
9. Patterns of antibody responses to nonviral cancer antigens in head and neck squamous cell carcinoma patients differ by human papillomavirus status.
Gangkofner DS; Holzinger D; Schroeder L; Eichmüller SB; Zörnig I; Jäger D; Wichmann G; Dietz A; Broglie MA; Herold-Mende C; Dyckhoff G; Boscolo-Rizzo P; Ezic J; Marienfeld RB; Möller P; Völkel G; Kraus JM; Kestler HA; Brunner C; Schuler PJ; Wigand M; Theodoraki MN; Doescher J; Hoffmann TK; Pawlita M; Butt J; Waterboer T; Laban S
Int J Cancer; 2019 Dec; 145(12):3436-3444. PubMed ID: 31407331
[TBL] [Abstract][Full Text] [Related]
10. Antibody Responses to Cancer Antigens Identify Patients with a Poor Prognosis among HPV-Positive and HPV-Negative Head and Neck Squamous Cell Carcinoma Patients.
Laban S; Gangkofner DS; Holzinger D; Schroeder L; Eichmüller SB; Zörnig I; Jäger D; Wichmann G; Dietz A; Broglie MA; Herold-Mende CC; Dyckhoff G; Boscolo-Rizzo P; Ezić J; Marienfeld R; Möller P; Kraus JM; Völkel G; Kestler HA; Brunner C; Schuler PJ; Wigand MC; Theodoraki MN; Doescher J; Hoffmann TK; Pawlita M; Waterboer T; Butt J
Clin Cancer Res; 2019 Dec; 25(24):7405-7412. PubMed ID: 31444248
[TBL] [Abstract][Full Text] [Related]
11. Comprehensive T-cell immunophenotyping and next-generation sequencing of human papillomavirus (HPV)-positive and HPV-negative head and neck squamous cell carcinomas.
Poropatich K; Fontanarosa J; Swaminathan S; Dittmann D; Chen S; Samant S; Zhang B
J Pathol; 2017 Nov; 243(3):354-365. PubMed ID: 28771750
[TBL] [Abstract][Full Text] [Related]
12. APOBEC mutagenesis is tightly linked to the immune landscape and immunotherapy biomarkers in head and neck squamous cell carcinoma.
Faden DL; Ding F; Lin Y; Zhai S; Kuo F; Chan TA; Morris LG; Ferris RL
Oral Oncol; 2019 Sep; 96():140-147. PubMed ID: 31422205
[TBL] [Abstract][Full Text] [Related]
13. HPV16 E5 Mediates Resistance to PD-L1 Blockade and Can Be Targeted with Rimantadine in Head and Neck Cancer.
Miyauchi S; Sanders PD; Guram K; Kim SS; Paolini F; Venuti A; Cohen EEW; Gutkind JS; Califano JA; Sharabi AB
Cancer Res; 2020 Feb; 80(4):732-746. PubMed ID: 31848196
[TBL] [Abstract][Full Text] [Related]
14. The promise of immunotherapy in head and neck squamous cell carcinoma.
Economopoulou P; Agelaki S; Perisanidis C; Giotakis EI; Psyrri A
Ann Oncol; 2016 Sep; 27(9):1675-85. PubMed ID: 27380958
[TBL] [Abstract][Full Text] [Related]
15. Peripheral blood monocyte and T-lymphocyte activation levels at diagnosis predict long-term survival in head and neck squamous cell carcinoma patients.
Aarstad HJ; Vintermyr OK; Ulvestad E; Aarstad HH; Kross KW; Heimdal JH
APMIS; 2015 Apr; 123(4):305-14. PubMed ID: 25801083
[TBL] [Abstract][Full Text] [Related]
16. Promising systemic immunotherapies in head and neck squamous cell carcinoma.
Gildener-Leapman N; Ferris RL; Bauman JE
Oral Oncol; 2013 Dec; 49(12):1089-96. PubMed ID: 24126223
[TBL] [Abstract][Full Text] [Related]
17. The Microenvironment of Head and Neck Cancers: Papillomavirus Involvement and Potential Impact of Immunomodulatory Treatments.
Outh-Gauer S; Morini A; Tartour E; Lépine C; Jung AC; Badoual C
Head Neck Pathol; 2020 Jun; 14(2):330-340. PubMed ID: 32124416
[TBL] [Abstract][Full Text] [Related]
18. Improving head and neck cancer therapies by immunomodulation of the tumour microenvironment.
Ruffin AT; Li H; Vujanovic L; Zandberg DP; Ferris RL; Bruno TC
Nat Rev Cancer; 2023 Mar; 23(3):173-188. PubMed ID: 36456755
[TBL] [Abstract][Full Text] [Related]
19. Distinct immune evasion in APOBEC-enriched, HPV-negative HNSCC.
Messerschmidt C; Obermayer B; Klinghammer K; Ochsenreither S; Treue D; Stenzinger A; Glimm H; Fröhling S; Kindler T; Brandts CH; Schulze-Osthoff K; Weichert W; Tinhofer I; Klauschen F; Keilholz U; Beule D; Rieke DT
Int J Cancer; 2020 Oct; 147(8):2293-2302. PubMed ID: 32468570
[TBL] [Abstract][Full Text] [Related]
20. Importance of the immune system in head and neck cancer.
Mirza AH; Thomas G; Ottensmeier CH; King EV
Head Neck; 2019 Aug; 41(8):2789-2800. PubMed ID: 30821023
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
